PureTech Health (PRTC) Return on Capital Employed (2025)
PureTech Health (PRTC) reported Return on Capital Employed of 31.2% for Q2 2025.
PureTech Health (PRTC) Return on Capital Employed (2025) Analysis & Trends
PureTech Health (PRTC) has 1 years of Return on Capital Employed data on file, last reported at 31.2% in Q2 2025.
- Return on Capital Employed for Q2 2025 came in at 31.2%, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was 31.2% (changed N/A YoY), and the FY2025 annual result was 18.86%, up 356.0% from the prior year.
- Return on Capital Employed held at 31.2% in Q2 2025 per PRTC's latest filing.
- Over five years, Return on Capital Employed peaked at 31.2% in Q2 2025 and troughed at 31.2% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -31.20% |